Sports Medicine Research and Testing Laboratory, Salt Lake City, Utah, USA.
United States Anti-Doping Agency, Colorado Springs, Colorado, USA.
Drug Test Anal. 2022 Jul;14(7):1291-1299. doi: 10.1002/dta.3254. Epub 2022 Mar 28.
The hematological module of the Athlete Biological Passport (ABP) represents an important tool in the pursuit to detect blood doping in athletes. Currently, collecting blood samples for ABP analysis can be cumbersome, invasive, and expensive, involving a venous blood draw performed by a trained phlebotomist followed by cold-chain monitored shipping to the analysis laboratory. Developing innovative methods to collect and transport ABP blood samples while adhering to strict preanalytical and analytical requirements has the potential to greatly increase testing frequency and, consequently, the effectiveness of the ABP program globally. The focus of this study was to compare venous blood collections with capillary blood collections to determine if capillary samples could be used for ABP analysis without sacrificing the analytical integrity required for antidoping testing procedures. In this study, capillary blood was collected using the Tasso+ EDTA device (Tasso, Inc.), a novel microvolumetric device that collects liquid, whole blood from skin capillaries on the upper arm. Excellent laboratory agreement was observed between venous and capillary blood samples for the three main ABP parameters: HGB, RET%, and OFF-Score. Additionally, the stability of capillary samples after storage at 4°C, similar to what would be required during transport, was acceptable for up to 72 h following collection. Finally, we generated individual ABP profiles using the adaptive model for 10 participants and observed excellent agreement between venous and capillary profiles. These results indicate capillary blood collection is a viable alternative to venous blood collections for ABP analysis.
运动员生物护照(ABP)的血液学模块是检测运动员血液兴奋剂的重要工具。目前,采集 ABP 分析用血液样本既繁琐、具侵入性,又昂贵,需要由经过培训的采血员采集静脉血,然后在冷链监控下运输到分析实验室。开发创新的方法来采集和运输 ABP 血液样本,同时遵守严格的分析前和分析要求,有可能大大增加检测频率,从而提高 ABP 项目在全球范围内的有效性。本研究的重点是比较静脉血采集与毛细血管血采集,以确定毛细血管样本是否可用于 ABP 分析,而不会牺牲抗兴奋剂检测程序所需的分析完整性。在这项研究中,使用 Tasso+EDTA 设备(Tasso,Inc.)采集毛细血管血,这是一种新颖的微容量设备,可从手臂上部的毛细血管采集液体全血。静脉血和毛细血管血样本在三个主要 ABP 参数(HGB、RET%和 OFF-Score)方面具有极好的实验室一致性。此外,在 4°C 下储存后,类似于运输过程中所需的储存条件,毛细血管样本在采集后长达 72 小时内的稳定性可接受。最后,我们使用自适应模型为 10 名参与者生成了个体 ABP 图谱,并观察到静脉和毛细血管图谱之间具有极好的一致性。这些结果表明,毛细血管血采集是 ABP 分析中替代静脉血采集的可行方法。